Corticosteroids in septic shock

New England Journal of Medicine

Volumn 358, Issue 2, 2008, Pages 188-190

  Finfer, Simon ^a,b,c  

^a GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; CORTICOTROPIN; ETOMIDATE; FLUDROCORTISONE; HYDROCORTISONE; PLACEBO; ANTIINFLAMMATORY AGENT;

CLINICAL TRIAL; CORTICOTROPIN TEST; DRUG FATALITY; DRUG INHIBITION; DRUG MEGADOSE; DRUG RESPONSE; EDITORIAL; HEALTH CARE SYSTEM; HUMAN; META ANALYSIS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOM ERROR; SEPTIC SHOCK; SYSTEMATIC REVIEW; NOTE; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS; HUMANS; HYDROCORTISONE; SHOCK, SEPTIC; TREATMENT FAILURE;

EID: 38049103768     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0708098     Document Type: Editorial

References (15)

1. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.
2. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659-65.
3. Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-8.
4. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337:582-3.
5. Annane D, Bellissant E, Sebille V, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998;46:589-97.
6. Rai R, Cohen J, Venkatesh B. Assessment of adrenocortical function in the critically ill. Crit Care Resusc 2004;6:123-9.
7. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004;350:1629-38.
8. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-50.
9. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-32.
10. Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
11. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73. [Errata, Crit Care Med 2004;32:1448, 2169-70.]
12. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004;141:47-56.
13. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004;329:480.
14. Cook DJ, Brower R, Cooper J, Brochard L, Vincent JL. Multicenter clinical research in adult critical care. Crit Care Med 2002;30:1636-43.
15. Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ. Randomized, controlled clinical trials in sepsis: has methodological quality improved over time? Crit Care Med 2002;30:461-72.